For more VICC news, visit their website »
Vanderbilt-Ingram Cancer Center, Meharry Medical College and Tennessee State University Cancer Partnership recently hosted the 2018 annual retreat and poster contest, “Health Disparities in Cancer Immunology & Immune Therapy.”
James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.
Twenty-three volunteer leaders have been named to fill positions on three of Vanderbilt University Medical Center’s (VUMC) advisory boards and councils.
Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.
Theresa Sberna, MPH, has been named director of Strategy and Analytics for Vanderbilt-Ingram Cancer Center (VICC). Sberna, who previously served as associate director, has been with the Cancer Center for five years.
Rising obesity rates in several Southern states are leading to a rapid increase in new cases of diabetes among both black and white adults. A new study helmed by investigators at the University of Texas Health Science Center and Vanderbilt University Medical Center (VUMC) found the risk of diabetes is double for black patients.
Accessibility Tools